CClinicalTrials.gg
TerminatedNCT05542238Updated Mar 6, 2025

The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury

An interventional study of One bout of moderate-intensity sub-maximal aerobic exercise in Spinal Cord Injuries, Cardiovascular Abnormalities and Cerebrovascular Disease; Sequelae, sponsored by State University of New York at Buffalo. Terminated at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-06.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Supportive care

Why this study was terminated
We have enrolled all the required participants for this pilot study.
Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The aims of this proposal are to: 1) investigate whether individuals with spinal cord injury (SCI) demonstrate cardiac autonomic, cerebrovascular, and cognitive dysfunctions compared to non-injured age- and sex-matched controls in the following conditions: supine rest and head-up tilt/face-cooling test; 2) examine if autonomic completeness/ incompleteness, physical activity, and psychological distress are predictors for dysfunctions during supine rest and head-up tilt/face cooling conditions in SCI individuals; 3) examine if one bout of moderate-intensity aerobic exercise temporarily improves cardiac autonomic and cerebrovascular functions and thereby improves cognition when in supine rest and head- up tilt/face cooling conditions. The study will include an initial visit and an experimental visit to our lab. Three groups of participants will be included in this study: Group 1, SCI with acute exercise; group 2, SCI with rest-control; and group 3, age- and sex-matched non-injured individuals. Cardiovascular variables, such as heart rate variability, blood pressure variability, and cerebrovascular variables, such as cerebral blood flow velocity and oxygenated hemoglobin, and cognitive performance will be examined. The investigator hypothesizes that individuals with SCI will have impaired cardiac autonomic, cerebrovascular, and cognitive functions compared to the non-injured controls, and an acute exercise can improve those functions. Autonomic completeness/incompleteness, physical activity, and psychological distress are significant factors that predict cardiac autonomic, cerebrovascular, and cognitive functions in individuals with SCI.

02

Conditions studied

  • Spinal Cord Injuries
  • Cardiovascular Abnormalities
  • Cerebrovascular Disease; Sequelae
  • Cognitive Impairment
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 6 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

State University of New York at Buffalo is the lead sponsor of 287 studies on the registry; 65 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Spinal cord injury group:

  • Males or females with chronic SCI (i.e. at least 6 months after the initial injury)
  • International Standard for Neurological Classification of SCI (ISNCSCI) A-D
  • Neurological level of injury C6 or below
  • 18-55 years old
  • Proficient in English
  • Able to detect middle cerebral artery blood velocity (MCAv) and/or posterior cerebral artery blood velocity (PCAv) signals through TCD

Non-injured controls:

  • Males or females without SCI
  • 18-55 years old
  • Proficient in English
  • Able to detect MCAv and/or PCAv signals through TCD

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular, pulmonary or respiratory diseases, or diabetes mellitus, any other diseases/disorders affecting cardiac autonomic nervous system, such as glaucoma and attention deficit hyperactivity disorder (ADHD)
  • Color Blindness
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
6 participants (actual)

Study arms

  • Active comparator
    CON

    Age-and sex-matched healthy controls with exercise intervention

    Behavioral: One bout of moderate-intensity sub-maximal aerobic exercise

  • Experimental
    SCI

    Individuals with spinal cord injury

    Behavioral: One bout of moderate-intensity sub-maximal aerobic exercise

Interventions

  • BehavioralOne bout of moderate-intensity sub-maximal aerobic exercise

    The intervention is a 20-min acute exercise using arm ergometer

06

What researchers measure

Primary outcomes

  1. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During baseline pre the 20-min acute exercise

  2. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During baseline pre the 20-min acute exercise

  3. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During face-cooling test pre the 20-min acute exercise

  4. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During face-cooling test pre the 20-min acute exercise

  5. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During head-up tilt test pre the 20-min acute exercise

  6. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During head-up tilt test pre the 20-min acute exercise

  7. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During cognitive tests pre the 20-min acute exercise

  8. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During cognitive tests pre the 20-min acute exercise

  9. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During baseline post the 20-min acute exercise

  10. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During face-cooling post the 20-min acute exercise

  11. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During face-cooling post the 20-min acute exercise

  12. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During head-up tilt test post the 20-min acute exercise

  13. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During head-up tilt test post the 20-min acute exercise

  14. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg\^2

    Time frame: During cognitive tests post the 20-min acute exercise

  15. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm\^2

    Time frame: During cognitive tests post the 20-min acute exercise

  16. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During baseline pre the 20-min acute exercise

  17. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During the face-cooling test pre the 20-min acute exercise

  18. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During the head-up tilt test pre the 20-min acute exercise

  19. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During the cognitive tests pre the 20-min acute exercise

  20. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During baseline post the 20-min acute exercise

  21. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During the face-cooling test post the 20-min acute exercise

  22. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During the head-up tilt test post the 20-min acute exercise

  23. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Time frame: During the cognitive tests post the 20-min acute exercise

  24. Cerebral oxygenation level

    Cerebral oxygenated hemoglobin in unknown unit

    Time frame: Change from baseline to the cognitive tests pre the 20-min acute exercise

  25. Cerebral oxygenation level

    Cerebral oxygenated hemoglobin in unknown unit

    Time frame: Change from baseline to the cognitive tests post the 20-min acute exercise

  26. Cognitive function

    Reaction time in second

    Time frame: During baseline pre the 20-min acute exercise

  27. Cognitive function

    Error made during the cognitive test in number

    Time frame: During baseline pre the 20-min acute exercise

  28. Cognitive function

    Reaction time in second

    Time frame: During head-up tilt pre the 20-min acute exercise

  29. Cognitive function

    Error made during the cognitive test in number

    Time frame: During head-up tilt pre the 20-min acute exercise

  30. Cognitive function

    Reaction time in second

    Time frame: During baseline post the 20-min acute exercise

  31. Cognitive function

    Error made during cognitive test in number

    Time frame: During baseline post the 20-min acute exercise

  32. Cognitive function

    Reaction time in second

    Time frame: During head-up tilt post the 20-min acute exercise

  33. Cognitive function

    Error made during the cognitive test in number

    Time frame: During head-up tilt post the 20-min acute exercise

07

Study locations

1 site
  • Department of Rehabilitation Sciences at University at Buffalo
    Buffalo, New York 14214, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05542238
Lead sponsor
State University of New York at Buffalo
Responsible party
Wenjie Ji (PhD student, State University of New York at Buffalo) — Principal investigator
First posted
Sep 15, 2022
Start date
Sep 6, 2022
Primary completion
Dec 18, 2024
Completion
Dec 18, 2024
Last update
Mar 6, 2025

Study contacts

Wenjie Ji, MS
principal investigator · University at Buffalo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion